High Symptom Burden Predicts Poorer Quality of Life Among Children and Adolescents Receiving Hematopoietic Stem Cell Transplantation or Chimeric Antigen Receptor T-Cell Therapy.

Kathleen E MontgomeryJennifer L RaybinKimberly PowersMelody HellstenPaula MurrayJessica Ward

Published in: Cancer nursing (2024)

Children experiencing high symptom burden should receive frequent assessment and enhanced symptom management throughout the treatment trajectory to mitigate negative impacts on quality of life.

Keyphrases

cell therapy
patient reported
stem cells
young adults
mesenchymal stem cells
acute myeloid leukemia